topics / erythropoietic protoporphyria

Tagged erythropoietic protoporphyria.

Preliminary human Afamelanotide (Melanotan-1): An Approved Orphan Drug With Modest, Single-Sponsor Evidence Afamelanotide is an FDA- and EMA-approved implant for a rare light-sensitivity disease. The trial evidence is real but modest, and it is not the gray-market tanning drug.